Target Price | €49.56 |
Price | €42.04 |
Potential | 17.91% |
Number of Estimates | 17 |
17 Analysts have issued a price target Qiagen 2026 . The average Qiagen target price is €49.56. This is 17.91% higher than the current stock price. The highest price target is €54.83 30.44% , the lowest is €44.23 5.22% . | |
A rating was issued by 20 analysts: 11 Analysts recommend Qiagen to buy, 9 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Qiagen stock has an average upside potential 2026 of 17.91% . Most analysts recommend the Qiagen stock at Purchase. |
18 Analysts have issued a sales forecast Qiagen 2024 . The average Qiagen sales estimate is €1.9b . This is 4.32% higher than the revenue of the last 12 months(TTM). The highest sales forecast is €1.9b 6.40% , the lowest is €1.8b 0.92% .
This results in the following potential growth metrics:
2023 | €1.8b | 10.79% |
---|---|---|
2024 | €1.9b | 4.10% |
2025 | €2.0b | 4.70% |
2026 | €2.1b | 6.66% |
2027 | €2.3b | 6.85% |
2028 | €2.5b | 8.65% |
16 Analysts have issued an Qiagen EBITDA forecast 2024. The average Qiagen EBITDA estimate is €672m . This is 6.97% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is €754m 19.94% , the lowest is €551m 12.32% .
This results in the following potential growth metrics and future EBITDA Margins:
2023 | €602m | 19.40% |
---|---|---|
2024 | €672m | 11.72% |
2025 | €727m | 8.10% |
2026 | €787m | 8.32% |
2027 | €841m | 6.86% |
2028 | €915m | 8.77% |
2023 | 33.10% | 9.65% |
---|---|---|
2024 | 35.53% | 7.33% |
2025 | 36.68% | 3.24% |
2026 | 37.25% | 1.55% |
2027 | 37.25% | 0.00% |
2028 | 37.29% | 0.11% |
7 Qiagen Analysts have issued a net profit forecast 2024. The average Qiagen net profit estimate is €93.7m . This is 14.09% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is €107m 30.18% , the lowest is €77.8m 5.29% .
This results in the following potential growth metrics and future Net Margins:
2023 | €313m | 22.04% |
---|---|---|
2024 | €93.7m | 70.10% |
2025 | €421m | 349.28% |
2026 | €471m | 11.89% |
2027 | €518m | 10.07% |
2028 | €579m | 11.61% |
2023 | 17.24% | 12.62% |
---|---|---|
2024 | 4.95% | 71.28% |
2025 | 21.24% | 329.09% |
2026 | 22.28% | 4.90% |
2027 | 22.95% | 3.01% |
2028 | 23.58% | 2.75% |
7 Analysts have issued a Qiagen forecast for earnings per share. The average Qiagen <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is €0.43 . This is 13.16% higher than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is €0.49 28.95% , the lowest is €0.36 5.26% .
This results in the following potential growth metrics and future valuations:
2023 | €1.45 | 22.04% |
---|---|---|
2024 | €0.43 | 70.34% |
2025 | €1.95 | 353.49% |
2026 | €2.18 | 11.79% |
2027 | €2.40 | 10.09% |
2028 | €2.68 | 11.67% |
Current | 112.09 | 292.33% |
---|---|---|
2024 | 96.95 | 13.51% |
2025 | 21.58 | 77.74% |
2026 | 19.29 | 10.61% |
2027 | 17.52 | 9.18% |
2028 | 15.70 | 10.39% |
Based on analysts' sales estimates for 2024, the Qiagen stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of 5.04 and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of 4.84 .
This results in the following potential growth metrics and future valuations:
Current | 5.26 | 4.16% |
---|---|---|
2024 | 5.04 | 4.12% |
2025 | 4.82 | 4.49% |
2026 | 4.52 | 6.25% |
2027 | 4.23 | 6.41% |
2028 | 3.89 | 7.96% |
Current | 5.04 | 4.78% |
---|---|---|
2024 | 4.84 | 4.14% |
2025 | 4.62 | 4.49% |
2026 | 4.33 | 6.25% |
2027 | 4.05 | 6.41% |
2028 | 3.73 | 7.96% |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.